USP Pharmaceutical Analytical Impurities

(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-N-methylbenzamide)

((2-Methyl-4-nitro-1H-imidazol-1-yl)acetic acid)

(N-Benzyl-2-{[5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carbonyl]oxy}-N-methylethan-1-amine oxide)

(10 mg

((6R,7R)-7-[2-(1H-tetrazol-1-yl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)

(2-(2-{4-[(2-Chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid)

(tert-Butyl 4-nitrosopiperazine-1-carboxylate)

(N-(3,4-Dimethoxyphenethyl)-N-methylnitrous amide)

(11Beta,21-Dihydroxypregna-1,4-diene-3,20-dione)

(11beta,17alpha-dihydroxy-3-oxo-androsta-1,4-diene-17-carboxaldehyde)

(11beta,17alpha-Dihydroxyandrosta-1,4-diene-3-one 17beta-carboxylic acid)

(Isopropyl 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate)

(17,21-Dihydroxypregn-4-ene-3,20-dione)

(4-(4-Hydroxy-phenoxy)-3,5-diiodophenylacetic acid)

(3-{2-[4-(Benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)

(rel-(2R,3S)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanethioamide)

((2S,3S)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanethioamide)

((4-amino-2-methylphenyl)(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)methanone)

((S)-4-(8-amino-3-(1-(3-oxobutanoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide)

((S)-5-chloro-N-(2-hydroxy-3-(nitroso(4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)

(2-bromo-5-nitroso-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine)

(3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,3,5-trifluorophenyl)butan-1-one phosphate)

(3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,3,6-trifluorophenyl)butan-1-one phosphate)